Omni Nutraceuticals Inc. has retained the services of Rabobank International to help the company explore strategic alternatives, including a possible sale. The Street paid little attention to the Oct. 20 news, as the microcap’s stock moved down just two cents to close at $1.54. At press time, it traded at $1.56.
To read the entire story, you must be logged in.
Please log in now or register with us.
